TAKE peers

Companies like TAKElatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

TAKE₹11.06

TAKE Limited

· Pharma & Health
₹ CrorePeersVIMTALABSSUVENMcap ₹164 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
TAKE
FY26
VIMTALABS
FY24
SUVEN
FY26
Peer
Average
Valuation — at last close
P/E◆ 14.95×28.08×—28.08× -47%
P/B5.27×◆ 3.60×11.78×7.69× -32%
EV/EBITDA◆ -85.32×13.20×-23.30×-5.05× -1589%
Market Cap₹164 Cr₹1,152 Cr₹6,967 Cr₹4,060 Cr -96%
Growth
Revenue CAGR 3Y-34.07%◆ 14.74%-19.30%-2.28% -1394%
Revenue CAGR 5Y-41.25%◆ 8.40%-12.00%-1.80% -2192%
Net Income CAGR 3Y—24.20%—24.20%
Revenue YoY (latest Q)◆ 73981.22%10.09%91.02%50.55% +146238%
Net Income YoY (latest Q)◆ 216.76%112.16%-147.71%-17.78% +1319%
Profitability
EBITDA Margin-3.53%◆ 27.27%-3998.80%-1985.77% +100%
Net Income Margin◆ 20.02%12.89%-3884.13%-1935.62% +101%
Return on Common Equity◆ 42.11%13.64%-78.80%-32.58% +229%
Return on Capital Employed-7.46%◆ 16.16%-82.30%-33.07% +77%
Return on Assets◆ 29.84%10.76%-72.78%-31.01% +196%
Credit & Quality
Total Debt/Equity◆ 0.00×0.06×0.00×0.03× -100%
Interest Coverage-5.51×◆ 24.79×-1838.51×-906.86× +99%
Scale — latest FY
Revenue / Total Income₹54.2 Cr₹318 Cr₹7.1 Cr₹163 Cr -67%
Net Income₹10.8 Cr₹41 Cr−₹276 Cr−₹118 Cr +109%
Total Assets₹36.2 Cr₹400 Cr₹624 Cr₹512 Cr -93%
EPS₹0.74₹18.51₹-12.13₹3.19 -77%
Book Value per Share₹2.1₹144.2₹22.43₹83.32 -97%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.